| Year |
Citation |
Score |
| 2024 |
Handlin LJ, Macchi NL, Dumaire NLA, Salih L, Lessie EN, McCommis KS, Moutal A, Dai G. Membrane lipid nanodomains modulate HCN pacemaker channels in nociceptor DRG neurons. Nature Communications. 15: 9898. PMID 39548079 DOI: 10.1038/s41467-024-54053-z |
0.346 |
|
| 2024 |
Martin LF, Almuslim M, Ismail KA, Ibrahim MM, Moutal A, Cheng K, Stratton HJ, Price TJ, Vanderah TW, Olivera BM, Khanna R, Patwardhan A. The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance. Pain. PMID 39297754 DOI: 10.1097/j.pain.0000000000003391 |
0.531 |
|
| 2024 |
Dhanalakshmi C, Janakiraman U, Moutal A, Fukunaga K, Khanna R, Nelson MA. Corrigendum to "Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency" [Neurobiology of Disease 149 (2021) 105224]. Neurobiology of Disease. 106620. PMID 39097414 DOI: 10.1016/j.nbd.2024.106620 |
0.412 |
|
| 2024 |
Stratton H, Lee G, Dolatyari M, Ghetti A, Cotta T, Mitchell S, Yue X, Ibrahim M, Dumaire N, Salih L, Moutal A, François-Moutal L, Martin L, Navratilova E, Porreca F. Nociceptors are functionally male or female: from mouse to monkey to man. Brain : a Journal of Neurology. PMID 38829801 DOI: 10.1093/brain/awae179 |
0.302 |
|
| 2024 |
Martin L, Stratton HJ, Gomez K, Do LD, Loya-Lopez S, Tang C, Calderon-Rivera A, Ran D, Nunna V, Bellampalli SS, François-Moutal L, Dumaire N, Salih L, Luo S, Porreca F, ... ... Moutal A, et al. Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain. Biorxiv : the Preprint Server For Biology. PMID 38766071 DOI: 10.1101/2024.05.04.592533 |
0.622 |
|
| 2023 |
Gomez K, Santiago U, Nelson TS, Allen HN, Calderon-Rivera A, Hestehave S, Rodríguez Palma EJ, Zhou Y, Duran P, Loya-Lopez S, Zhu E, Kumar U, Shields R, Koseli E, McKiver B, ... ... Moutal A, et al. A peptidomimetic modulator of the Ca2.2 N-type calcium channel for chronic pain. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305215120. PMID 37972067 DOI: 10.1073/pnas.2305215120 |
0.509 |
|
| 2023 |
Gomez K, Allen HN, Duran P, Loya-Lopez S, Calderon-Rivera A, Moutal A, Tang C, Nelson TS, Perez-Miller S, Khanna R. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain. Pain. PMID 37862053 DOI: 10.1097/j.pain.0000000000003080 |
0.579 |
|
| 2023 |
Gomez K, Stratton HJ, Duran P, Loya S, Tang C, Calderon-Rivera A, François-Moutal L, Khanna M, Madura CL, Luo S, McKiver B, Choi E, Ran D, Boinon L, Perez-Miller S, ... ... Moutal A, et al. Identification and targeting of a unique Na1.7 domain driving chronic pain. Proceedings of the National Academy of Sciences of the United States of America. 120: e2217800120. PMID 37498871 DOI: 10.1073/pnas.2217800120 |
0.481 |
|
| 2023 |
Gomez K, Duran P, Tonello R, Allen HN, Boinon L, Calderon-Rivera A, Loya-López S, Nelson TS, Ran D, Moutal A, Bunnett NW, Khanna R. Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors. Pain. PMID 37366599 DOI: 10.1097/j.pain.0000000000002970 |
0.588 |
|
| 2023 |
Wu XQ, Tan B, Du Y, Yang L, Hu TT, Ding YL, Qiu XY, Moutal A, Khanna R, Yu J, Chen Z. Glutamatergic and GABAergic neurons in the vLGN mediate the nociceptive effects of green and red light on neuropathic pain. Neurobiology of Disease. 106164. PMID 37217103 DOI: 10.1016/j.nbd.2023.106164 |
0.483 |
|
| 2022 |
Stratton HJ, Boinon L, Gomez K, Martin L, Duran P, Ran D, Zhou Y, Luo S, Perez-Miller S, Patek M, Ibrahim MM, Patwardhan A, Moutal A, Khanna R. Targeting the vascular endothelial growth factor A/neuropilin 1 axis for relief of neuropathic pain. Pain. PMID 36729125 DOI: 10.1097/j.pain.0000000000002850 |
0.546 |
|
| 2022 |
Jiang YP, Wang S, Lai WD, Wu XQ, Jin Y, Xu ZH, Moutal A, Khanna R, Park KD, Shan ZM, Wen CP, Yu J. Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement. Arthritis Research & Therapy. 24: 277. PMID 36564853 DOI: 10.1186/s13075-022-02975-8 |
0.512 |
|
| 2022 |
Loya-López SI, Duran P, Ran D, Calderon-Rivera A, Gomez K, Moutal A, Khanna R. Cell specific regulation of NaV1.7 activity and trafficking in rat nodose ganglia neurons. Neurobiology of Pain (Cambridge, Mass.). 12: 100109. PMID 36531612 DOI: 10.1016/j.ynpai.2022.100109 |
0.583 |
|
| 2022 |
Duran P, Loya-López S, Ran D, Tang C, Calderon-Rivera A, Gomez K, Stratton HJ, Huang S, Xu YM, Wijeratne EMK, Perez-Miller S, Shan Z, Cai S, Gabrielsen AT, Dorame A, ... ... Moutal A, et al. The natural product Argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels. British Journal of Pharmacology. PMID 36245395 DOI: 10.1111/bph.15974 |
0.525 |
|
| 2022 |
Gomez K, Tang C, Tan B, Perez-Miller S, Ran D, Loya S, Calderon-Rivera A, Stratton HJ, Duran P, Masterson KA, Gabrielsen AT, Alsbiei O, Dorame A, Serafini M, Moutal A, et al. Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca Channels and Pain. Acs Chemical Neuroscience. PMID 35671441 DOI: 10.1021/acschemneuro.2c00256 |
0.514 |
|
| 2022 |
François-Moutal L, Scott DD, Ambrose AJ, Zerio CJ, Rodriguez-Sanchez M, Dissanayake K, May DG, Carlson JM, Barbieri E, Moutal A, Roux KJ, Shorter J, Khanna R, Barmada SJ, McGurk L, et al. Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology. Scientific Reports. 12: 8140. PMID 35581326 DOI: 10.1038/s41598-022-12191-8 |
0.394 |
|
| 2022 |
Ito H, Navratilova E, Vagnerova B, Watanabe M, Kopruszinski C, Moreira de Souza LH, Yue X, Ikegami D, Moutal A, Patwardhan A, Khanna R, Yamazaki M, Guerrero M, Rosen H, Roberts E, et al. Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance. Brain : a Journal of Neurology. PMID 35485490 DOI: 10.1093/brain/awac153 |
0.433 |
|
| 2022 |
Watanabe M, Kopruszinski CM, Moutal A, Ikegami D, Khanna R, Chen Y, Ross S, Mackenzie K, Stratton J, Dodick DW, Navratilova E, Porreca F. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. Brain : a Journal of Neurology. PMID 35325034 DOI: 10.1093/brain/awac104 |
0.453 |
|
| 2022 |
Boinon L, Yu J, Madura CL, Chefdeville A, Feinstein DL, Moutal A, Khanna R. Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain. Pain. 163: e368-e381. PMID 35029600 DOI: 10.1097/j.pain.0000000000002344 |
0.563 |
|
| 2021 |
Martin L, Ibrahim M, Gomez K, Yu J, Cai S, Chew LA, Bellampalli SS, Moutal A, Largent-Milnes T, Porreca F, Khanna R, Olivera BM, Patwardhan A. Conotoxin contulakin-G engages a neurotensin receptor 2 /R-type calcium channel (Cav2.3) pathway to mediate spinal antinociception. Pain. PMID 35050960 DOI: 10.1097/j.pain.0000000000002561 |
0.537 |
|
| 2021 |
Rivas CM, Schiff HV, Moutal A, Khanna R, Kiela PR, Dussor G, Price TJ, Vagner J, DeFea KA, Boitano S. Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression. Biochemical and Biophysical Research Communications. 591: 13-19. PMID 34990903 DOI: 10.1016/j.bbrc.2021.12.090 |
0.375 |
|
| 2021 |
Cai S, Moutal A, Yu J, Chew LA, Isensee J, Chawla R, Gomez K, Luo S, Zhou Y, Chefdeville A, Madura C, Perez-Miller S, Bellampalli SS, Dorame A, Scott DD, et al. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents. Science Translational Medicine. 13: eabh1314. PMID 34757807 DOI: 10.1126/scitranslmed.abh1314 |
0.473 |
|
| 2021 |
Ikegami D, Navratilova E, Yue X, Moutal A, Kopruszinski CM, Khanna R, Patwardhan A, Dodick DW, Porreca F. A prolactin-dependent sexually dimorphic mechanism of migraine chronification. Cephalalgia : An International Journal of Headache. 3331024211039813. PMID 34510920 DOI: 10.1177/03331024211039813 |
0.358 |
|
| 2021 |
Martin LF, Moutal A, Cheng K, Washington SM, Calligaro H, Goel V, Kranz T, Largent-Milnes TM, Khanna R, Patwardhan A, Ibrahim MM. Green light antinociceptive and reversal of thermal and mechanical hypersensitivity effects rely on endogenous opioid system stimulation. The Journal of Pain. PMID 34157406 DOI: 10.1016/j.jpain.2021.05.006 |
0.469 |
|
| 2021 |
Zhang H, Lipinski AA, Liktor-Busa E, Smith AF, Moutal A, Khanna R, Langlais PR, Largent-Milnes TM, Vanderah TW. The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area. Frontiers in Pharmacology. 12: 632757. PMID 33953672 DOI: 10.3389/fphar.2021.632757 |
0.373 |
|
| 2021 |
Jeanne M, Demory H, Moutal A, Vuillaume ML, Blesson S, Thépault RA, Marouillat S, Halewa J, Maas SM, Motazacker MM, Mancini GMS, van Slegtenhorst MA, Andreou A, Cox H, Vogt J, et al. Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities. American Journal of Human Genetics. PMID 33894126 DOI: 10.1016/j.ajhg.2021.04.004 |
0.545 |
|
| 2021 |
Perez-Miller S, Patek M, Moutal A, Duran P, Cabel CR, Thorne CA, Campos SK, Khanna R. Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry. Acs Chemical Neuroscience. PMID 33787218 DOI: 10.1021/acschemneuro.0c00619 |
0.458 |
|
| 2021 |
Gomez K, Ran D, Madura CL, Moutal A, Khanna R. Non-SUMOylated CRMP2 decreases Na1.7 currents via the endocytic proteins Numb, Nedd4-2 and Eps15. Molecular Brain. 14: 20. PMID 33478555 DOI: 10.1186/s13041-020-00714-1 |
0.534 |
|
| 2021 |
Cai S, Gomez K, Moutal A, Khanna R. Targeting T-type/CaV3.2 channels for chronic pain. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 33422652 DOI: 10.1016/j.trsl.2021.01.002 |
0.572 |
|
| 2021 |
Ran D, Gomez K, Moutal A, Patek M, Perez-Miller S, Khanna R. Comparison of quinazoline and benzoylpyrazoline chemotypes targeting the CaVα-β interaction as antagonists of the N-type CaV2.2 channel. Channels (Austin, Tex.). 15: 128-135. PMID 33416017 DOI: 10.1080/19336950.2020.1863595 |
0.506 |
|
| 2020 |
Dhanalakshmi C, Janakiraman U, Moutal A, Fukunaga K, Khanna R, Nelson MA. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency. Neurobiology of Disease. 105224. PMID 33359140 DOI: 10.1016/j.nbd.2020.105224 |
0.47 |
|
| 2020 |
Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, Stratton HJ, Cai S, Luo S, Gonzalez KB, Perez-Miller S, Patwardhan A, Ibrahim MM, Khanna R. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. Pain. PMID 33009246 DOI: 10.1097/j.pain.0000000000002097 |
0.475 |
|
| 2020 |
Perez-Miller S, Patek M, Moutal A, Cabel CR, Thorne CA, Campos SK, Khanna R. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein. Biorxiv : the Preprint Server For Biology. PMID 32995772 DOI: 10.1101/2020.09.22.308783 |
0.463 |
|
| 2020 |
Krall RF, Moutal A, Phillips MB, Asraf H, Johnson JW, Khanna R, Hershfinkel M, Aizenman E, Tzounopoulos T. Synaptic zinc inhibition of NMDA receptors depends on the association of GluN2A with the zinc transporter ZnT1. Science Advances. 6. PMID 32937457 DOI: 10.1126/Sciadv.Abb1515 |
0.446 |
|
| 2020 |
Schulien AJ, Yeh CY, Orange BN, Pav OJ, Hopkins MP, Moutal A, Khanna R, Sun D, Justice JA, Aizenman E. Targeted disruption of Kv2.1-VAPA association provides neuroprotection against ischemic stroke in mice by declustering Kv2.1 channels. Science Advances. 6. PMID 32937450 DOI: 10.1126/Sciadv.Aaz8110 |
0.492 |
|
| 2020 |
Moutal A, Martin LF, Boinon L, Gomez K, Ran D, Zhou Y, Stratton HJ, Cai S, Luo S, Gonzalez KB, Perez-Miller S, Patwardhan A, Ibrahim MM, Khanna R. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. Biorxiv : the Preprint Server For Biology. PMID 32869019 DOI: 10.1101/2020.07.17.209288 |
0.475 |
|
| 2020 |
Quach TT, Moutal A, Khanna R, Deems NP, Duchemin AM, Barrientos RM. Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32804096 DOI: 10.3233/Jad-200721 |
0.474 |
|
| 2020 |
Gomez K, Vallecillo TGM, Moutal A, Perez-Miller S, Delgado-Lezama R, Felix R, Khanna R. The role of cyclin dependent kinase 5 (Cdk5) in neuropathic pain. Pain. PMID 32773603 DOI: 10.1097/J.Pain.0000000000002027 |
0.618 |
|
| 2020 |
Alles SRA, Gomez K, Moutal A, Khanna R. Putative roles of SLC7A5 (LAT1) transporter in pain. Neurobiology of Pain (Cambridge, Mass.). 8: 100050. PMID 32715162 DOI: 10.1016/J.Ynpai.2020.100050 |
0.612 |
|
| 2020 |
Khanna R, Moutal A, Perez-Miller S, Chefdeville A, Boinon L, Patek M. Druggability of CRMP2 for neurodegenerative diseases. Acs Chemical Neuroscience. PMID 32693579 DOI: 10.1021/Acschemneuro.0C00307 |
0.548 |
|
| 2020 |
Janakiraman U, Dhanalakshmi C, Yu J, Moutal A, Boinon L, Fukunaga K, Khanna R, Nelson MA. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome. Neurobiology of Disease. 143: 105006. PMID 32622085 DOI: 10.1016/J.Nbd.2020.105006 |
0.501 |
|
| 2020 |
Moutal A, Ji Y, Bellampalli SS, Khanna R. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury. Molecular Brain. 13: 97. PMID 32571373 DOI: 10.1186/S13041-020-00633-1 |
0.596 |
|
| 2020 |
Moutal A, Cai S, Yu J, Stratton HJ, Chefdeville A, Gomez K, Ran D, Madura CL, Boinon L, Soto M, Zhou Y, Shan Z, Chew LA, Rodgers KE, Khanna R. Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific NaV1.7 regulation in the pathogenesis of chronic neuropathic pain. Pain. PMID 32569093 DOI: 10.1097/J.Pain.0000000000001951 |
0.605 |
|
| 2020 |
Cai S, Tuohy P, Ma C, Kitamura N, Gomez K, Zhou Y, Ran D, Bellampalli SS, Yu J, Luo S, Dorame A, Ngan Pham NY, Molnar G, Streicher JM, Patek M, ... ... Moutal A, et al. A modulator of the low-voltage activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies. Pain. PMID 32541387 DOI: 10.1097/J.Pain.0000000000001955 |
0.575 |
|
| 2020 |
Stratton H, Boinon L, Moutal A, Khanna R. Coordinating Synaptic Signaling with CRMP2. The International Journal of Biochemistry & Cell Biology. 105759. PMID 32437854 DOI: 10.1016/J.Biocel.2020.105759 |
0.502 |
|
| 2020 |
Zhou Y, Cai S, Gomez K, Wijeratne EMK, Ji Y, Bellampalli SS, Luo S, Moutal A, Gunatilaka AAL, Khanna R. 1-O-Acetylgeopyxin A, a derivative of a fungal metabolite, blocks tetrodotoxin-sensitive voltage-gated sodium, calcium channels and neuronal excitability which correlates with inhibition of neuropathic pain. Molecular Brain. 13: 73. PMID 32393368 DOI: 10.1186/S13041-020-00616-2 |
0.608 |
|
| 2020 |
Chen Y, Moutal A, Navratilova E, Kopruszinski C, Yue X, Ikegami M, Chow M, Kanazawa I, Bellampalli SS, Xie J, Patwardhan A, Rice K, Fields H, Akopian A, Neugebauer V, et al. Erratum: The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females (Science Translational Medicine DOI: 10.1126/scitranslmed.aay7550) Science Translational Medicine. 12. PMID 32132219 DOI: 10.1126/Scitranslmed.Abb4549 |
0.458 |
|
| 2020 |
Chen Y, Moutal A, Navratilova E, Kopruszinski C, Yue X, Ikegami M, Chow M, Kanazawa I, Bellampalli SS, Xie J, Patwardhan A, Rice K, Fields H, Akopian A, Neugebauer V, et al. The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females. Science Translational Medicine. 12. PMID 32024801 DOI: 10.1126/Scitranslmed.Aay7550 |
0.519 |
|
| 2019 |
de Macedo FHP, Aires RD, Fonseca EG, Ferreira RCM, Machado DPD, Chen L, Zhang FX, Souza IA, Lemos VS, Romero TRL, Moutal A, Khanna R, Zamponi GW, Cruz JS. TNF-α mediated upregulation of Na1.7 currents in rat dorsal root ganglion neurons is independent of CRMP2 SUMOylation. Molecular Brain. 12: 117. PMID 31888677 DOI: 10.1186/S13041-019-0538-0 |
0.529 |
|
| 2019 |
Khanna R, Patwardhan A, Yang X, Li W, Cai S, Ji Y, Chew LA, Dorame A, Bellampalli SS, Schmoll RW, Gordon J, Moutal A, Vanderah TW, Porreca F, Ibrahim MM. Erratum to ‛Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light': The Journal of Pain 20 (2019) 1293-1306. The Journal of Pain : Official Journal of the American Pain Society. 20: 1509. PMID 31818395 DOI: 10.1016/J.Jpain.2019.11.012 |
0.528 |
|
| 2019 |
Moutal A, Kalinin S, Kowal K, Marangoni N, Dupree J, Lin SX, Lis K, Lisi L, Hensley K, Khanna R, Feinstein DL. Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis. Asn Neuro. 11: 1759091419892090. PMID 31795726 DOI: 10.1177/1759091419892090 |
0.471 |
|
| 2019 |
Zhou Y, Cai S, Moutal A, Yu J, Gomez K, Madura CL, Shan Z, Ngan Pham NY, Serafini MJ, Dorame A, Scott DD, Francois-Moutal L, Perez-Miller S, Patek M, Khanna M, et al. The natural flavonoid Naringenin elicits analgesia through inhibition of NaV1.8 voltage-gated sodium channels. Acs Chemical Neuroscience. PMID 31697467 DOI: 10.1021/Acschemneuro.9B00547 |
0.59 |
|
| 2019 |
Moutal A, Shan Z, Miranda VG, François-Moutal L, Madura CL, Khanna M, Khanna R. Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief. Channels (Austin, Tex.). 13: 498-504. PMID 31680630 DOI: 10.1080/19336950.2019.1684608 |
0.628 |
|
| 2019 |
Buchta WC, Moutal A, Hines B, Garcia-Keller C, Smith ACW, Kalivas P, Khanna R, Riegel AC. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking. Molecular Neurobiology. PMID 31359322 DOI: 10.1007/S12035-019-01711-9 |
0.475 |
|
| 2019 |
Janakiraman U, Yu J, Moutal A, Raman DS, Boinon L, Batchelor SN, Annadurai A, Khanna R, Nelson MA. TAF1-gene editing alters the morphology and function of the cerebellum. Neurobiology of Disease. 104539. PMID 31344492 DOI: 10.1016/J.Nbd.2019.104539 |
0.504 |
|
| 2019 |
Yeh CY, Ye Z, Moutal A, Gaur S, Henton AM, Kouvaros S, Saloman JL, Hartnett-Scott KA, Tzounopoulos T, Khanna R, Aizenman E, Camacho CJ. Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant. Proceedings of the National Academy of Sciences of the United States of America. PMID 31308225 DOI: 10.1073/Pnas.1903401116 |
0.535 |
|
| 2019 |
Khanna R, Moutal A, White KA, Chefdeville A, Negrao de Assis P, Cai S, Swier VJ, Bellampalli SS, Giunta MD, Darbro BW, Quelle DE, Sieren JC, Wallace MR, Rogers CS, Meyerholz DK, et al. Assessment of nociception and related quality of life measures in a porcine model of Neurofibromatosis type 1. Pain. PMID 31246731 DOI: 10.1097/J.Pain.0000000000001648 |
0.568 |
|
| 2019 |
Moutal A, Luo S, Largent-Milnes TM, Vanderah TW, Khanna R. Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Neurobiology of Pain (Cambridge, Mass.). 5. PMID 31080913 DOI: 10.1016/J.Ynpai.2018.07.003 |
0.602 |
|
| 2019 |
Khanna R, Patwardhan A, Yang X, Li W, Cai S, Ji Y, Chew LA, Dorame A, Bellampalli SS, Schmoll RW, Gordon J, Moutal A, Vanderah TW, Porreca F, Ibrahim MM. Development and Characterization of An Injury-free Model of Functional Pain in Rats by Exposure to Red Light. The Journal of Pain : Official Journal of the American Pain Society. PMID 31054915 DOI: 10.1016/J.Jpain.2019.04.008 |
0.549 |
|
| 2019 |
Cai S, Shan Z, Zhang Z, Moutal A, Khanna R. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons. Channels (Austin, Tex.). 13: 147-152. PMID 31025580 DOI: 10.1080/19336950.2019.1608129 |
0.55 |
|
| 2019 |
Shan Z, Cai S, Yu J, Zhang Z, Vallecillo TGM, Serafini MJ, Thomas AM, Pham NYN, Bellampalli SS, Moutal A, Zhou Y, Xu GB, Xu YM, Luo S, Patek M, et al. Reversal of peripheral neuropathic pain by the small-molecule natural product physalin F via block of CaV2.3 (R-type) and CaV2.2 (N-type) voltage-gated calcium channels. Acs Chemical Neuroscience. PMID 30946560 DOI: 10.1021/Acschemneuro.9B00166 |
0.596 |
|
| 2019 |
Khanna R, Yu J, Yang X, Moutal A, Chefdeville A, Gokhale V, Shuja Z, Chew LA, Bellampalli SS, Luo S, François-Moutal L, Serafini MJ, Ha T, Perez-Miller S, Park KD, et al. Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy. Pain. PMID 30933958 DOI: 10.1097/J.Pain.0000000000001524 |
0.616 |
|
| 2019 |
Moutal A, White KA, Chefdeville A, Laufmann RN, Vitiello PF, Feinstein D, Weimer JM, Khanna R. Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions. Molecular Neurobiology. PMID 30915713 DOI: 10.1007/S12035-019-1568-4 |
0.54 |
|
| 2019 |
Moutal A, Dustrude ET, Largent-Milnes TM, Vanderah TW, Khanna M, Khanna R. Blocking CRMP2 SUMOylation reverses neuropathic pain. Molecular Psychiatry. 23: 2119-2121. PMID 28533518 DOI: 10.1038/Mp.2017.117 |
0.489 |
|
| 2018 |
Hurst SE, Liktor-Busa E, Moutal A, Parker S, Rice S, Szelinger S, Senner G, Hammer MF, Johnstone L, Ramsey K, Narayanan V, Perez-Miller S, Khanna M, Dahlin H, Lewis K, et al. A novel variant in affects gene expression and is associated with X-linked intellectual disability syndrome. Neuronal Signaling. 2: NS20180141. PMID 32714589 DOI: 10.1042/NS20180141 |
0.406 |
|
| 2018 |
Yu J, Moutal A, Dorame A, Bellampalli SS, Chefdeville A, Kanazawa I, Pham NYN, Park KD, Weimer JM, Khanna R. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission. Molecular Neurobiology. PMID 30565051 DOI: 10.1007/S12035-018-1445-6 |
0.581 |
|
| 2018 |
Cai S, Bellampalli SS, Yu J, Li W, Ji Y, Wijeratne EMK, Dorame A, Luo S, Shan Z, Khanna M, Moutal A, Streicher JM, Gunatilaka AAL, Khanna R. (-)-Hardwickiic acid and Hautriwaic acid induce antinociception via blockade of tetrodotoxin-sensitive voltage-dependent sodium channels. Acs Chemical Neuroscience. PMID 30525440 DOI: 10.1021/Acschemneuro.8B00617 |
0.604 |
|
| 2018 |
Alberio L, Locarno A, Saponaro A, Romano E, Bercier V, Albadri S, Simeoni F, Moleri S, Pelucchi S, Porro A, Marcello E, Barsotti N, Kukovetz K, Boender AJ, Contestabile A, ... ... Moutal A, et al. A light-gated potassium channel for sustained neuronal inhibition. Nature Methods. PMID 30377377 DOI: 10.1038/S41592-018-0186-9 |
0.572 |
|
| 2018 |
Parker SS, Moutal A, Cai S, Chandrasekaran S, Roman MR, Koshy AA, Khanna R, Zinsmaier KE, Mouneimne G. High Fidelity Cryopreservation and Recovery of Primary Rodent Cortical Neurons. Eneuro. 5. PMID 30263951 DOI: 10.1523/ENEURO.0135-18.2018 |
0.412 |
|
| 2018 |
Bellampalli SS, Ji Y, Moutal A, Cai S, Wijeratne EMK, Gandini MA, Yu J, Chefdeville A, Dorame A, Chew LA, Madura CL, Luo S, Molnar G, Khanna M, Streicher JM, et al. Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels. Pain. PMID 30169422 DOI: 10.1097/J.Pain.0000000000001385 |
0.596 |
|
| 2018 |
Francois-Moutal L, Jahanbakhsh S, Nelson A, Ray D, Scott DD, Hennefarth M, Moutal A, Perez-Miller S, Ambrose AJ, Al-Shamari A, Coursodon P, Meechoovet B, Reiman R, Lyons E, Beilstein M, et al. A Chemical Biology Approach to Model Pontocerebellar Hypoplasia Type 1B (PCH1B). Acs Chemical Biology. PMID 30141626 DOI: 10.1021/Acschembio.8B00745 |
0.417 |
|
| 2018 |
White KA, Swier VJ, Cain JT, Kohlmeyer JL, Meyerholz DK, Tanas MR, Uthoff J, Hammond E, Li H, Rohret FA, Goeken A, Chan CH, Leidinger MR, Umesalma S, Wallace MR, ... ... Moutal A, et al. A porcine model of neurofibromatosis type 1 that mimics the human disease. Jci Insight. 3. PMID 29925695 DOI: 10.1172/Jci.Insight.120402 |
0.475 |
|
| 2018 |
François-Moutal L, Dustrude ET, Wang Y, Brustovetsky T, Dorame A, Ju W, Moutal A, Perez-Miller S, Brustovetsky N, Gokhale V, Khanna M, Khanna R. Inhibition of the Ubc9 E2 SUMO conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain. Pain. PMID 29847471 DOI: 10.1097/J.Pain.0000000000001294 |
0.61 |
|
| 2018 |
Moutal A, Sun L, Yang X, Li W, Cai S, Luo S, Khanna R. CRMP2 Neurofibromin Interface Drives NF1-related Pain. Neuroscience. PMID 29655575 DOI: 10.1016/J.Neuroscience.2018.04.002 |
0.57 |
|
| 2018 |
Parrilla-Carrero J, Buchta WC, Goswamee P, Culver O, McKendrick G, Harlan B, Moutal A, Penrod R, Khanna R, Kalivas P, Riegel AC. Restoration of Kv7 channel mediated inhibition reduces cued-reinstatement of cocaine seeking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29636392 DOI: 10.1523/Jneurosci.2767-17.2018 |
0.502 |
|
| 2018 |
Moutal A, Khanna R. Unconventional Signaling by Extracellular CRMP2: Possible Role as an Atypical Neurotransmitter? Neuroscience. 376: 224-226. PMID 29555038 DOI: 10.1016/J.Neuroscience.2018.02.025 |
0.436 |
|
| 2017 |
Naudet N, Moutal A, Vu HN, Chounlamountri N, Watrin C, Cavagna S, Malleval C, Benetollo C, Bardel C, Dronne MA, Honnorat J, Meissirel C, Besançon R. Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5. Cellular and Molecular Life Sciences : Cmls. PMID 28864883 DOI: 10.1007/S00018-017-2634-6 |
0.537 |
|
| 2017 |
Moutal A, Cai S, Luo S, Voisin R, Khanna R. CRMP2 is necessary for Neurofibromatosis type 1 related pain. Channels (Austin, Tex.). 0. PMID 28837387 DOI: 10.1080/19336950.2017.1370524 |
0.606 |
|
| 2017 |
Moutal A, Yang X, Li W, Gilbraith KB, Luo S, Cai S, François-Moutal L, Chew LA, Yeon SK, Bellampalli SS, Qu C, Xie JY, Ibrahim MM, Khanna M, Park KD, et al. CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide. Pain. PMID 28809766 DOI: 10.1097/J.Pain.0000000000001002 |
0.608 |
|
| 2017 |
Moutal A, Wang Y, Yang X, Ji Y, Luo S, Dorame A, Bellampalli SS, Chew LA, Cai S, Dustrude ET, Keener JE, Marty MT, Vanderah TW, Khanna R. Dissecting the role of the CRMP2-Neurofibromin complex on pain behaviors. Pain. PMID 28767512 DOI: 10.1097/J.Pain.0000000000001026 |
0.601 |
|
| 2017 |
Moutal A, Villa LS, Yeon SK, Householder KT, Park KD, Sirianni RW, Khanna R. CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation. Molecular Neurobiology. PMID 28660485 DOI: 10.1007/S12035-017-0653-9 |
0.48 |
|
| 2017 |
Sandweiss AJ, McIntosh MI, Moutal A, Davidson-Knapp R, Hu J, Giri AK, Yamamoto T, Hruby VJ, Khanna R, Largent-Milnes TM, Vanderah TW. Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. Molecular Psychiatry. PMID 28485408 DOI: 10.1038/Mp.2017.102 |
0.548 |
|
| 2017 |
Yeh CY, Bulas AM, Moutal A, Saloman JL, Hartnett KA, Anderson CT, Tzounopoulos T, Sun D, Khanna R, Aizenman E. Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28483976 DOI: 10.1523/Jneurosci.3811-16.2017 |
0.528 |
|
| 2017 |
Dustrude ET, Perez-Miller S, François-Moutal L, Moutal A, Khanna M, Khanna R. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function. Channels (Austin, Tex.). 0. PMID 28277940 DOI: 10.1080/19336950.2017.1299838 |
0.486 |
|
| 2017 |
Moutal A, Li W, Wang Y, Ju W, Luo S, Cai S, François-Moutal L, Perez-Miller S, Hu J, Dustrude ET, Vanderah TW, Gokhale V, Khanna M, Khanna R. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of CRMP2-derived peptides. British Journal of Pharmacology. PMID 28161890 DOI: 10.1111/Bph.13737 |
0.618 |
|
| 2017 |
Ibrahim MM, Patwardhan A, Gilbraith KB, Moutal A, Yang X, Chew LA, Largent-Milnes T, Malan TP, Vanderah TW, Porreca F, Khanna R. Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. Pain. 158: 347-360. PMID 28092651 DOI: 10.1097/J.Pain.0000000000000767 |
0.568 |
|
| 2016 |
Dustrude ET, Moutal A, Yang X, Wang Y, Khanna M, Khanna R. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proceedings of the National Academy of Sciences of the United States of America. PMID 27940916 DOI: 10.1073/Pnas.1610531113 |
0.593 |
|
| 2016 |
Moutal A, Eyde N, Telemi E, Park KD, Xie JY, Dodick DW, Porreca F, Khanna R. Efficacy of (S)-Lacosamide in preclinical models of cephalic pain. Pain Reports (Baltimore, Md.). 1. PMID 27917413 DOI: 10.1097/PR9.0000000000000565 |
0.514 |
|
| 2016 |
Xie JY, Chew LA, Yang X, Wang Y, Qu C, Wang Y, Federici LM, Fitz SD, Ripsch MS, Due MR, Moutal A, Khanna M, White FA, Vanderah TW, Johnson PL, et al. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential. Pain. 157: 2124-2140. PMID 27537210 DOI: 10.1097/J.Pain.0000000000000628 |
0.595 |
|
| 2016 |
Moutal A, Dustrude ET, Khanna R. Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1. Molecular Neurobiology. PMID 27167129 DOI: 10.1007/S12035-016-9907-1 |
0.501 |
|
| 2016 |
Moutal A, Chew LA, Yang X, Wang Y, Yeon SK, Telemi E, Meroueh S, Park KD, Shrinivasan R, Gilbraith KB, Qu C, Xie JY, Patwardhan A, Vanderah TW, Khanna M, et al. (S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Pain. PMID 26967696 DOI: 10.1097/J.Pain.0000000000000555 |
0.625 |
|
| 2015 |
Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur ME, Besançon R, Naudet N, Magadoux L, Khanna R, Ducray F, Meyronet D, et al. CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling. Cancer Research. 75: 3519-28. PMID 26122847 DOI: 10.1158/0008-5472.Can-14-0631 |
0.741 |
|
| 2015 |
Moutal A, François-Moutal L, Perez-Miller S, Cottier K, Chew LA, Yeon SK, Dai J, Park KD, Khanna M, Khanna R. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. Molecular Neurobiology. PMID 25846820 DOI: 10.1007/S12035-015-9141-2 |
0.504 |
|
| 2015 |
François-Moutal L, Wang Y, Moutal A, Cottier KE, Melemedjian OK, Yang X, Wang Y, Ju W, Largent-Milnes TM, Khanna M, Vanderah TW, Khanna R. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. Pain. 156: 1247-64. PMID 25782368 DOI: 10.1097/j.pain.0000000000000147 |
0.522 |
|
| 2015 |
Wang Y, Francois-Moutal L, Moutal A, Cottier K, Melemedjian O, Khanna M, Vanderah T, Khanna R. (399) A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses post-operative pain behaviors The Journal of Pain. 16: S75. DOI: 10.1016/J.Jpain.2015.01.318 |
0.502 |
|
| 2014 |
Moutal A, François-Moutal L, Brittain JM, Khanna M, Khanna R. Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. Frontiers in Cellular Neuroscience. 8: 471. PMID 25674050 DOI: 10.3389/Fncel.2014.00471 |
0.485 |
|
| 2014 |
Wilson SM, Moutal A, Melemedjian OK, Wang Y, Ju W, François-Moutal L, Khanna M, Khanna R. The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. Frontiers in Cellular Neuroscience. 8: 196. PMID 25104922 DOI: 10.3389/Fncel.2014.00196 |
0.529 |
|
| Show low-probability matches. |